Annexin Pharmaceuticals AB (ANNX) — Tangible Net Worth Ratio
Annexin Pharmaceuticals AB (ANNX) has a Tangible Net Worth Ratio of 99.0% as of March 2026. This metric is calculated by deducting intangible assets (Skr139.00K) from net assets (Skr14.42 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See ANNX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Annexin Pharmaceuticals AB Tangible Net Worth Ratio (2014–2025)
This chart shows how Annexin Pharmaceuticals AB's Tangible Net Worth Ratio has changed across 11 annual periods from 2014 to 2025. As of March 2026, the ratio stands at 99.0%, reflecting net assets of Skr14.42 Million with intangible assets of Skr139.00K SEK. See ANNX cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Annexin Pharmaceuticals AB (2014–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Annexin Pharmaceuticals AB from 2014 to 2025, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see ANNX market cap overview.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.3% | Skr24.93 Million | Skr164.00K | Skr30.16 Million | ▲ +1.3 pp |
| 2024 | 98.0% | Skr13.71 Million | Skr268.00K | Skr19.04 Million | ▲ +0.0 pp |
| 2023 | 98.0% | Skr18.81 Million | Skr371.00K | Skr26.76 Million | ▼ -0.4 pp |
| 2022 | 98.4% | Skr30.15 Million | Skr474.00K | Skr36.68 Million | ▼ -0.3 pp |
| 2021 | 98.8% | Skr46.73 Million | Skr577.00K | Skr52.79 Million | ▲ +2.1 pp |
| 2020 | 96.7% | Skr20.64 Million | Skr680.00K | Skr25.16 Million | ▲ +3.5 pp |
| 2019 | 93.2% | Skr11.49 Million | Skr783.00K | Skr16.04 Million | ▼ -4.6 pp |
| 2018 | 97.8% | Skr39.85 Million | Skr887.00K | Skr46.04 Million | ▲ +1.8 pp |
| 2017 | 95.9% | Skr24.44 Million | Skr990.00K | Skr30.85 Million | ▲ +4.8 pp |
| 2016 | 91.2% | Skr15.57 Million | Skr1.38 Million | Skr23.46 Million | ▲ +49.0 pp |
| 2014 | 42.1% | Skr2.71 Million | Skr1.57 Million | Skr3.69 Million | — |